Gesynta Pharma
Michaela Gertz (born in 1981) holds an MSc in Business and Economics from Uppsala University. She has more than 15 years of experience in positions as CFO, Investor Relations Manager, and Head of Investor Relations & Financing in several life science companies listed on Nasdaq Stockholm.
Gesynta Pharma
Developing unique drug candidates aiming to reduce harmful inflammation and increase blood flow in the body’s microvasculature.